December 26, 2011
At a meeting on December 22, Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) Committee on Reevaluation recommended designating the reevaluation of two active pharmaceutical ingredients (APIs) similar to Takeda Pharmaceutical’s anti-inflammatory enzyme drug Dasen (serrapeptase). The Committee requires pharmaceutical companies...read more